Literature DB >> 19387319

Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.

Otmane Nafidi1, Real W Lapointe, Raymond Lepage, Rajiv Kumar, Pierre D'Amour.   

Abstract

OBJECTIVE: To determine precisely the role of parathyroid hormone (PTH) and of phosphatonins in the genesis of posthepatectomy hypophosphatemia.
BACKGROUND: Posthepatectomy hypophosphatemia has recently been related to increased renal fractional excretion of phosphate (FE P). To address the cause of hypophosphatemia, we measured serum concentrations of PTH, various phosphatonins, and the number of removed hepatic segment in patients with this disorder.
METHODS: Serum phosphate (PO4), ionized calcium (Ca++), HCO3-, pH and FE P, intact PTH (I-PTH), carboxyl-terminal fibroblast growth factor 23 (C-FGF-23) and intact fibroblast growth factor 23 (I-FGF-23), FGF-7, and secreted frizzled related-protein-4 (sFRP-4) were measured before and on postoperative (po) days 1, 2, 3, 5, and 7, in 18 patients undergoing liver resection. The number of removed hepatic segments was also assessed.
RESULTS: Serum PO4 concentrations decreased within 24 hours, were lowest (0.66 +/- 0.03 mmol/L; P < 0.001) at 48 hours, and returned to normal within 5 days of the procedure. FE P peaked at 25.07% +/- 2.26% on po day 1 (P < 0.05). Decreased ionized calcium concentrations (1.10 +/- 0.01 mmol/L; P < 0.01) were observed on po day 1 and were negatively correlated with increased I-PTH concentrations (8.8 +/- 0.9 pmol/L; P < 0.01; correlation: r = -0.062, P = 0.016). FE P was positively related to I-PTH levels on po day 1 (r = 0.52, P = 0.047) and negatively related to PO4 concentrations (r = -0.56, P = 0.024). Severe hypophosphatemia and increased urinary phosphate excretion persisted for 72 hours even when I-PTH concentrations had returned to normal. I-FGF-23 decreased to its nadir of 7.8 +/- 6.9 pg/mL (P < 0.001) on po day 3 and was correlated with PO4 levels on po days 0, 3, 5, and 7 (P < 0.001). C-FGF-23, FGF-7 and sFRP-4 levels could not be related to either PO4 concentrations or FE P.
CONCLUSION: Posthepatectomy hypophosphatemia is associated with increased FE P unrelated to I-FGF-23 or C-FGF-23, FGF-7, or sFRP-4. I-PTH contributes to excessive FE P partially on po day 1 but not thereafter. Other yet defined factors should explain post hepatectomy hypophosphatemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387319      PMCID: PMC3899889          DOI: 10.1097/SLA.0b013e3181a3e562

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  30 in total

1.  Fibroblast growth factor receptors and their ligands in the adult rat kidney.

Authors:  B Cancilla; A Davies; J A Cauchi; G P Risbridger; J F Bertram
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

2.  Reduced red cell 2,3-diphosphoglycerate and adenosine triphosphate, hypophosphatemia, and increased hemoglobin-oxygen affinity after cardiac surgery.

Authors:  J A Young; M A Lichtman; J Cohen
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

3.  Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis.

Authors:  P M Ambühl; D Meier; B Wolf; U Dydak; P Boesiger; U Binswanger
Journal:  Am J Kidney Dis       Date:  1999-11       Impact factor: 8.860

4.  Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c.

Authors:  M E Guicciardi; J Deussing; H Miyoshi; S F Bronk; P A Svingen; C Peters; S H Kaufmann; G J Gores
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

5.  Hypophosphatemia following open heart surgery: incidence and consequences.

Authors:  Jonathan Cohen; Alex Kogan; Gideon Sahar; Shaul Lev; Bernardo Vidne; Pierre Singer
Journal:  Eur J Cardiothorac Surg       Date:  2004-08       Impact factor: 4.191

6.  Intracellular inorganic phosphate and ATP levels in human blood erythrocytes, leucocytes and platelets in normal subjects and in diseases associated with altered phosphate metabolism.

Authors:  C J Preston; A Noorwali; A Challa; A D Paterson; D J Beard; J A Kanis; R G Russell
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

7.  Defective adenosine triphosphate synthesis. An explanation for skeletal muscle dysfunction in phosphate-deficient mice.

Authors:  B D Hettleman; R L Sabina; M K Drezner; E W Holmes; J L Swain
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

Review 8.  The phosphatonin pathway: new insights in phosphate homeostasis.

Authors:  Susan C Schiavi; Rajiv Kumar
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

9.  Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.

Authors:  Theresa Berndt; Theodore A Craig; Ann E Bowe; John Vassiliadis; David Reczek; Richard Finnegan; Suzanne M Jan De Beur; Susan C Schiavi; Rajiv Kumar
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 10.  Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.

Authors:  Aisha Shaikh; Theresa Berndt; Rajiv Kumar
Journal:  Pediatr Nephrol       Date:  2008-02-21       Impact factor: 3.714

View more
  13 in total

Review 1.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 2.  Regulation of renal phosphate handling: inter-organ communication in health and disease.

Authors:  Sawako Tatsumi; Atsumi Miyagawa; Ichiro Kaneko; Yuji Shiozaki; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2015-08-22       Impact factor: 2.626

Review 3.  FGF23 and syndromes of abnormal renal phosphate handling.

Authors:  Clemens Bergwitz; Harald Jüppner
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Approach to the hypophosphatemic patient.

Authors:  Erik A Imel; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2012-03       Impact factor: 5.958

5.  Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase.

Authors:  Jian Zheng; Ilya G Glezerman; Eran Sadot; Anjuli McNeil; Cristina Zarama; Mithat Gönen; John Creasy; Linda M Pak; Vinod P Balachandran; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin; Edgar A Jaimes
Journal:  J Am Coll Surg       Date:  2017-07-06       Impact factor: 6.113

6.  Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives.

Authors:  Shahid G Farid; K Rajendra Prasad; Gareth Morris-Stiff
Journal:  World J Gastrointest Surg       Date:  2013-05-27

7.  Impact of Perioperative Phosphorus and Glucose Levels on Liver Regeneration and Long-term Outcomes after Major Liver Resection.

Authors:  Georgios Antonios Margonis; Neda Amini; Stefan Buettner; Mounes Aliyari Ghasebeh; Sepideh Besharati; Yuhree Kim; Faiz Gani; Fatemeh Sobhani; Mario Samaha; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-04-27       Impact factor: 3.452

8.  Hepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis.

Authors:  Kengo Nomura; Sawako Tatsumi; Atsumi Miyagawa; Yuji Shiozaki; Shohei Sasaki; Ichiro Kaneko; Mikiko Ito; Shinsuke Kido; Hiroko Segawa; Mitsue Sano; Tsutomu Fukuwatari; Katsumi Shibata; Ken-ichi Miyamoto
Journal:  J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 10.121

9.  Hypophosphataemia after major hepatectomy and the risk of post-operative hepatic insufficiency and mortality: an analysis of 719 patients.

Authors:  Malcolm H Squires; Gregory C Dann; Neha L Lad; Sarah B Fisher; Benjamin M Martin; David A Kooby; Juan M Sarmiento; Maria C Russell; Kenneth Cardona; Charles A Staley; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2014-05-15       Impact factor: 3.647

10.  Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation.

Authors:  Christoph Zechner; Beverley Adams-Huet; Blake Gregory; Javier A Neyra; Jody A Rule; Xilong Li; Jorge Rakela; Orson W Moe; William M Lee
Journal:  Transl Res       Date:  2021-07-21       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.